| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.084 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 6.084 | 297 | 0 | 0 | 379 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 26.173 | 3.185 | 1.954 | 1.148 | 765 | 477 | 123 | 72 | 0 | 0 |
| Gross Profit/Loss - EUR | -20.088 | -2.889 | -1.954 | -1.148 | -386 | -477 | -123 | -72 | 0 | 0 |
| Net Profit/Loss - EUR | -20.377 | -2.919 | -1.954 | -1.148 | -397 | -477 | -123 | -72 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Liantica Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.016 | 3.499 | 1.857 | 1.033 | 421 | 198 | 71 | 0 | 0 | 0 |
| Current Assets | 10 | 469 | 48 | 42 | 335 | 26 | 25 | 25 | 25 | 25 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 274 | 0 | 0 | 0 | 0 | 0 |
| Cash | 10 | 469 | 48 | 42 | 61 | 26 | 25 | 25 | 25 | 25 |
| Shareholders Funds | -47.567 | -50.001 | -51.108 | -51.318 | -50.721 | -50.237 | -49.246 | -49.470 | -49.320 | -49.044 |
| Social Capital | 945 | 935 | 919 | 903 | 885 | 868 | 849 | 852 | 849 | 844 |
| Debts | 54.593 | 53.969 | 53.012 | 52.405 | 51.478 | 50.461 | 49.342 | 49.495 | 49.345 | 49.069 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Liantica Medical Srl